NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1051 coverAUTOIMMUNE DISEASES AND TREATMENT: Organ-Specific and Systemic Disorders Volume 1051 published June 2005
Ann. N.Y. Acad. Sci. 1051: 730–742 (2005). doi: 10.1196/annals.1361.117
Copyright © 2005 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by AUCI, D
Articles by READING, C
Search for Related Content
PubMed
PubMed Citation
Articles by AUCI, D
Articles by READING, C
Anti-inflammatory and Immune Regulatory Properties of 5-Androsten-3ß, 17ß-Diol (HE2100), and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases

D AUCIa, F NICOLETTIb, K MANGANOb, R PIETERSc, S NIERKENSc, L MORGANa, H OFFNERd, J FRINCKEa AND C READINGa

aHollis-Eden Pharmaceuticals, San Diego, California, USA
bDepartment of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy
cInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands
dDepartment of Neurology, Oregon Health and Science University, Portland, Oregon, USA

Address for correspondence: Dominick L. Auci, 4435 Eastgate Mall, Suite 400, San Diego, CA 92121. Voice: 858-320-2582; fax: 858-558-6470. Dauci{at}holliseden.com

5-Androsten-3ß, 17ß-diol (HE2100), and a synthetic analogue HE3204 are regarded as immune-regulating hormones, because both induce changes in the reporter antigen-popliteal lymph node assay (RA-PLNA). Mice were injected in the footpad with either HE2100 or HE3204 (0.01-3 mg), and a nonsensitizing dose of trinitrophenyl ovalbumin (TNP-OVA) was used as bystander reporter antigen. Seven days later, nodes were removed and numbers of cells (CD3, CD4, CD8, CD19; flow cytometry), TNP-specific IgM, IgG1, and IgG2a antibody-forming cells (AFCs; ELISPOT assay), and cytokines (interleukin-4 [IL-4], interferon-{gamma} [IFN-{gamma}]; ELISA) were measured. HE2100 and HE3204 increased cell numbers in a dose-dependent fashion. T (helper and suppressor) cells and B cells were increased (>5-fold). HE3204 was apparently twice as potent as HE2100. Both increased the B/T ratio (fivefold), increased TNP-specific IgM and IgG1 (~50-fold), and induced IgG2a AFCs. Both increased IL-4 and IFN-{gamma} secretion (up to threefold). Both displayed anti-inflammatory activity in the murine model of carrageenan-induced pleurisy, as evidenced by reduced neutrophil numbers and exudate volumes. Our observations suggest that both HE2100 and HE3204 are immune-regulating steroid hormones that exhibit anti-inflammatory properties. HE2100 (1 mg/mouse per day) provided significant benefit when given at disease onset in the SJL/J female mouse model of experimental autoimmune encephalomyelitis. These compounds and their analogues are candidates for further testing in autoimmune diseases.

Key Words: steroids • DHEA • autoimmune disease • immune-regulating hormones






footerLeft footerRight